e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Airway inflammation: pharmacological mechanisms and novel targets
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD
C. Estornut (Valencia, Spain), I. Roger (Valencia, Spain), B. Ballester (Valencia, Spain), P. Ribera (Valencia, Spain), J. Cortijo (Valencia, Spain)
Source:
International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Session:
Airway inflammation: pharmacological mechanisms and novel targets
Session type:
Thematic Poster
Number:
4216
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Estornut (Valencia, Spain), I. Roger (Valencia, Spain), B. Ballester (Valencia, Spain), P. Ribera (Valencia, Spain), J. Cortijo (Valencia, Spain). ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD. 4216
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
INCREASED MYOSTATIN AS A NEGATIVE REGULATOR OF MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: CLINICAL IMPLICATIONS
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020
OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
PREVALENCE OF SENSITIZATION TO AVIAN OR FUNGAL PROTEINS IN DIFFERENT WORK ENVIRONMENTS.
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018
MONITORING IMMUNODYNAMICS IN IMMUNE CHECKPOINT INHIBITOR THERAPY FOR STAGE IIIB/IV NON-SMALL CELL LUNG CANCER
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
ARE THERE CLINICALLY RELEVANT BENEFITS IN A STRUCTURED PROGRAM OF PHYSICAL ACTIVITY IN COPD? ACTIVEPOC STUDY.
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020
DEFICIENT MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: ROLE OF SATELLITE CELLS
Source: International Congress 2019 – Lung function and respiratory muscle testing
Year: 2019
THE ASSOCIATION ANALYSIS OF CHEMILUMINESCENCE OF NEUTROPHILS OF THE BLOOD WITH PATHOGENETIC FACTORS OF COPD
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
DETERMINATION OF EQUATIONS OF THE REFERENCE VALUES FOR THE STATE OF SÃO PAULO POPULATION IN TEST OF INCREMENTAL RESPIRATORY ENDURANCE (TIRE).
Source: International Congress 2019 – New views on testing and training of respiratory muscles
Year: 2019
TRANSCRIPTOMIC PROFILING REVEALS M1-HIGH TUMOUR ASSOCIATED MACROPHAGES THAT ORCHESTRATE THE ADAPTIVE ANTI-TUMOUR RESPONSE IN HUMAN LUNG CANCER
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017
IS IRON DEFICIENCY MODULATING PHYSICAL ACTIVITY IN COPD?
Source: International Congress 2017 – Best abstracts in physical activity and management of COPD
Year: 2017
PURINERGIC SIGNALING AND LYMPHOID ORGANS ARE INVOLVED IN THE BENEFICIAL EFFECTS OF AEROBIC TRAINING IN ASTHMA
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
BENEFITS OF MEASURED ISOTIMING IN CONSTANT CARDIOPULMONARY EXERCISE TESTING IN A STRUCTURED PHYSICAL ACTIVITY PROGRAM
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020
FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP)
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
EVALUATION OF SMALL AIRWAY DISEASE (SAD) IN ASTHMA. CONCORDANCES AND DISCREPANCES BETWEEN DIFFERENT TECHNIQUES.
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
INFLUENCE OF INDUCED IMMUNOSUPRESSION ON INFLAMMATION AND LUNGS REMODELING ON THE COPD MODEL
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
BLOOD PRESSURE EFFECTS OF OBSTRUCTIVE SLEEP APNEA TREATMENT BY CONTINUOUS POSITIVE AIRWAY PRESSURE: SYSTEMATIC REVIEW, METAANALYSIS AND EVALUATION OF PHENOTYPES PREDICTING RESPONSE
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019
“A RANDOMISED CONTROLLED STUDY ON EFFECT OF ORAL MAGNESIUM SUPPLEMENTS IN CONTROL OF SYMPTOMS OF BRONCHIAL ASTHMA AND LUNG FUNCTION PARAMETERS”
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
HOME MONITORING WITH A PORTABLE OXYMETER AS AN ALTERNATIVE METHOD TO ASSESS OXYGEN SATURATION DURING DAILY ACTIVITIES IN INTERSTITIAL LUNG DISEASES (ILDs).
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
SLEEP APNOEA AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE: CURRENT EVIDENCE, BASIC MECHANISMS AND RESEARCH PRIORITIES.
Source: Eur Respir J 2007; 29: 614
Year: 2007
COMPARISON OF PHYSICAL PERFORMANCE AND SPIROMETRY VALUES ACCORDING TO FALL RISK OF COPD SUBJECTS
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept